Curcumin Is an In Vivo Inhibitor of Angiogenesis
Jack L. Arbiser, Nancy Klauber, Richard M. Rohan, Robert van Leeuwen, Mou-Tuan Huang, Carolyn Fisher, Evelyn Flynn, H. Randolph Byers
Abstract
Open-access reader
Jack L. Arbiser, Nancy Klauber, Richard M. Rohan, Robert van Leeuwen, Mou-Tuan Huang, Carolyn Fisher, Evelyn Flynn, H. Randolph Byers
Abstract
Open-access reader
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 403 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Curcumin, Angiogenesis, Basic fibroblast growth factor, In vivo, Neovascularization, Vascular endothelial growth factor, Carcinogenesis, Pharmacology